FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2960914521> ?p ?o ?g. }

• W2960914521 endingPage "489" @default.
• W2960914521 startingPage "480" @default.
• W2960914521 abstract "Opioids promote tumor angiogenesis in mammary malignancies, but the underlying signaling mechanism is largely unknown. The current study investigated the hypothesis that stimulation of δ-opioid receptors (DOR) in breast cancer (BCa) cells activates the hypoxia-inducible factor 1α (HIF-1α), which triggers synthesis and release of diverse angiogenic factors. Immunoblotting revealed that incubation of human MCF-7 and T47D breast cancer cells with the DOR agonist d-Ala2,d-Leu5-enkephalin (DADLE) resulted in a transient accumulation and thus activation of HIF-1α DADLE-induced HIF-1α activation preceded PI3K/Akt stimulation and was blocked by the DOR antagonist naltrindole and naloxone, pertussis toxin, different phosphoinositide 3-kinase (PI3K) inhibitors, and the Akt inhibitor Akti-1/2. Whereas DADLE exposure had no effect on the expression and secretion of vascular endothelial growth factor (VEGF) in BCa cells, an increased abundance of cyclooxygenase-2 (COX-2) and release of prostaglandin E2 (PGE2) was detected. DADLE-induced COX-2 expression was also observed in three-dimensional cultured MCF-7 cells and impaired by PI3K/Akt inhibitors and the HIF-1α inhibitor echinomycin. Supernatant from DADLE-treated MCF-7 cells triggered sprouting of endothelial (END) cells, which was blocked when MCF-7 cells were pretreated with echinomycin or the COX-2 inhibitor celecoxib. Also no sprouting was observed when END cells were exposed to the PGE2 receptor antagonist PF-04418948. The findings together indicate that DOR stimulation in BCa cells leads to PI3K/Akt-dependent HIF-1α activation and COX-2 expression, which trigger END cell sprouting by paracrine activation of PGE2 receptors. These findings provide a potential mechanism of opioid-driven tumor angiogenesis and thus therapeutic targets to combat the tumor-angiogenic opioid effect. SIGNIFICANCE STATEMENT: Opioids are indispensable analgesics for treating cancer-related pain. However, opioids were found to promote tumor growth and metastasis, which questions the use of these potent pain-relieving drugs in cancer patients. Enhanced tumor vascularization after opioid treatment implies that tumor progression results from angiogenic opioid effects. Thus, understanding the signaling mechanism of opioid-driven tumor angiogenesis helps to identify therapeutic targets to combat these undesired tumor effects. The present study reveals that stimulation of δ-opioid receptors in breast cancer cells leads to an activation of HIF-1α and expression of COX-2 via PI3K/Akt stimulation, which results in a paracrine activation of vascular endothelial cells by prostaglandin E2 receptors." @default.
• W2960914521 created "2019-07-23" @default.
• W2960914521 creator A5023248587 @default.
• W2960914521 creator A5031005930 @default.
• W2960914521 creator A5058033139 @default.
• W2960914521 creator A5070334459 @default.
• W2960914521 date "2019-07-12" @default.
• W2960914521 modified "2023-10-17" @default.
• W2960914521 title "Activation of HIF-1<i>α</i>by<i>δ</i>-Opioid Receptors Induces COX-2 Expression in Breast Cancer Cells and Leads to Paracrine Activation of Vascular Endothelial Cells" @default.
• W2960914521 cites W1038585844 @default.
• W2960914521 cites W1529396499 @default.
• W2960914521 cites W1561176015 @default.
• W2960914521 cites W1726025741 @default.
• W2960914521 cites W1776637350 @default.
• W2960914521 cites W1965939769 @default.
• W2960914521 cites W1966052610 @default.
• W2960914521 cites W1967151011 @default.
• W2960914521 cites W1970034970 @default.
• W2960914521 cites W1970490725 @default.
• W2960914521 cites W1975454216 @default.
• W2960914521 cites W1976655389 @default.
• W2960914521 cites W1977913176 @default.
• W2960914521 cites W1981211047 @default.
• W2960914521 cites W1984139177 @default.
• W2960914521 cites W1986248688 @default.
• W2960914521 cites W1991346678 @default.
• W2960914521 cites W1995347532 @default.
• W2960914521 cites W1998260007 @default.
• W2960914521 cites W2000976163 @default.
• W2960914521 cites W2003336769 @default.
• W2960914521 cites W2003493239 @default.
• W2960914521 cites W2004221441 @default.
• W2960914521 cites W2004262765 @default.
• W2960914521 cites W2008854828 @default.
• W2960914521 cites W2017663673 @default.
• W2960914521 cites W2022745640 @default.
• W2960914521 cites W2024289681 @default.
• W2960914521 cites W2033160938 @default.
• W2960914521 cites W2033453582 @default.
• W2960914521 cites W2036022311 @default.
• W2960914521 cites W2039313320 @default.
• W2960914521 cites W2043023167 @default.
• W2960914521 cites W2051491878 @default.
• W2960914521 cites W2051619902 @default.
• W2960914521 cites W2056341285 @default.
• W2960914521 cites W2058138221 @default.
• W2960914521 cites W2059153388 @default.
• W2960914521 cites W2071361463 @default.
• W2960914521 cites W2071998745 @default.
• W2960914521 cites W2074883812 @default.
• W2960914521 cites W2075054245 @default.
• W2960914521 cites W2078659604 @default.
• W2960914521 cites W2082066164 @default.
• W2960914521 cites W2085316933 @default.
• W2960914521 cites W2085879736 @default.
• W2960914521 cites W2092344671 @default.
• W2960914521 cites W2093014461 @default.
• W2960914521 cites W2098405997 @default.
• W2960914521 cites W2102246235 @default.
• W2960914521 cites W2107277218 @default.
• W2960914521 cites W2110678035 @default.
• W2960914521 cites W2112911107 @default.
• W2960914521 cites W2113017071 @default.
• W2960914521 cites W2114229735 @default.
• W2960914521 cites W2120090919 @default.
• W2960914521 cites W2125785650 @default.
• W2960914521 cites W2129873928 @default.
• W2960914521 cites W2130522035 @default.
• W2960914521 cites W2144670533 @default.
• W2960914521 cites W2152053318 @default.
• W2960914521 cites W2158906680 @default.
• W2960914521 cites W2163069245 @default.
• W2960914521 cites W2166083817 @default.
• W2960914521 cites W2166798256 @default.
• W2960914521 cites W2167473316 @default.
• W2960914521 cites W2168714103 @default.
• W2960914521 cites W2256561018 @default.
• W2960914521 cites W2263821617 @default.
• W2960914521 cites W2300955327 @default.
• W2960914521 cites W2462818054 @default.
• W2960914521 cites W2521168381 @default.
• W2960914521 cites W2546933714 @default.
• W2960914521 cites W2558232235 @default.
• W2960914521 cites W2597805119 @default.
• W2960914521 cites W2748372326 @default.
• W2960914521 cites W2770247709 @default.
• W2960914521 cites W2805565785 @default.
• W2960914521 doi "https://doi.org/10.1124/jpet.119.257501" @default.
• W2960914521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31300611" @default.
• W2960914521 hasPublicationYear "2019" @default.
• W2960914521 type Work @default.
• W2960914521 sameAs 2960914521 @default.
• W2960914521 citedByCount "18" @default.
• W2960914521 countsByYear W29609145212020 @default.
• W2960914521 countsByYear W29609145212021 @default.
• W2960914521 countsByYear W29609145212022 @default.
• W2960914521 countsByYear W29609145212023 @default.
• W2960914521 crossrefType "journal-article" @default.

• next